Rapid progression to invasive cervix cancer in a woman infected with the human immunodeficiency virus

被引:29
作者
Holcomb, K
Maiman, M
Dimaio, T
Gates, J
机构
[1] SUNY Hlth Sci Ctr, Div Gynecol Oncol, Dept Obstet & Gynecol, Brooklyn, NY USA
[2] SUNY Hlth Sci Ctr, Dept Anat Pathol, Brooklyn, NY USA
关键词
D O I
10.1016/S0029-7844(97)00607-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Previous studies have shown an increased risk of cervical dysplasia in women infected with human immunodeficiency virus (HIV), as well as an increased risk of progression to higher-grade lesions. It is not known whether the rate of progression is accelerated over that in immunocompetent women. Case: During September 1991, an HIV-positive woman underwent conization of the cervix showing carcinoma in situ. The surgical margins and endocervical curettings were negative for dysplasia. Papanicolaou smears 4 and 7 months after the conization also were negative. She then presented 33 months postconization with a stage Ib2 cervical carcinoma, which proved resistant to chemotherapy and pelvic radiation. Conclusion: Immunosuppression caused by HIV infection may cause a more rapid progression of cervical intraepithelial lesions to carcinoma. (C) 1998 by The American College of Obstetricians and Gynecologists.
引用
收藏
页码:848 / 850
页数:3
相关论文
共 8 条
[1]   PROGRESSION OF HUMAN PAPILLOMAVIRUS TYPE-18-IMMORTALIZED HUMAN KERATINOCYTES TO A MALIGNANT PHENOTYPE [J].
HURLIN, PJ ;
KAUR, P ;
SMITH, PP ;
PEREZREYES, N ;
BLANTON, RA ;
MCDOUGALL, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :570-574
[2]   HIGH-FREQUENCY OF LATENT AND CLINICAL HUMAN PAPILLOMAVIRUS CERVICAL INFECTIONS IN IMMUNOCOMPROMISED HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN [J].
JOHNSON, JC ;
BURNETT, AF ;
WILLET, GD ;
YOUNG, MA ;
DONIGER, J .
OBSTETRICS AND GYNECOLOGY, 1992, 79 (03) :321-327
[3]   HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CERVICAL NEOPLASIA [J].
MAIMAN, M ;
FRUCHTER, RG ;
SERUR, E ;
REMY, JC ;
FEUER, G ;
BOYCE, J .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :377-382
[4]   HUMAN IMMUNODEFICIENCY VIRUS-INDUCED IMMUNOSUPPRESSION - A RISK FACTOR FOR HUMAN PAPILLOMAVIRUS INFECTION [J].
MATORRAS, R ;
ARICETA, JM ;
REMENTERIA, A ;
CORRAL, J ;
DETERAN, GG ;
DIEZ, J ;
MONTOYA, F ;
RODRIGUEZESCUDERO, FJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (01) :42-44
[5]  
MCINDOE WA, 1984, OBSTET GYNECOL, V64, P451
[6]   CELLULAR IMMUNODEFICIENCY ENHANCES THE PROGRESSION OF HUMAN PAPILLOMAVIRUS-ASSOCIATED CERVICAL LESIONS [J].
PETRY, KU ;
SCHEFFEL, D ;
BODE, U ;
GABRYSIAK, T ;
KOCHEL, H ;
KUPSCH, E ;
GLAUBITZ, M ;
NIESERT, S ;
KUHNLE, H ;
SCHEDEL, I .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (06) :836-840
[7]  
PORRECO R, 1975, OBSTET GYNECOL, V45, P359
[8]   CARCINOMA OF THE CERVIX FOLLOWING CONSERVATIVE MANAGEMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA [J].
SHUMSKY, AG ;
STUART, GCE ;
NATION, J .
GYNECOLOGIC ONCOLOGY, 1994, 53 (01) :50-54